PD-1 Resistant Head and Neck Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

1. Ayala Pharmaceuticals D srl.
2. Amgen Inc.
3. AstraZeneca plc.
4. Boehringer Ingelheim International GmbH
5. Bristol-Myers Squibb Company
6. Cel-Sci
7. GSK plc
8. Incyte
9. Merck KGaA
10. Novartis AG.